Antifungal Drugs in Newborns and Children
- PMID: 29173792
- DOI: 10.1016/j.pcl.2017.08.013
Antifungal Drugs in Newborns and Children
Abstract
Invasive fungal infections are a significant cause of morbidity and mortality in infants and children. Early diagnosis is critical, and treatment with the appropriate drug and dose should be initiated promptly. Although an increasing number of studies have examined dosing of antifungals in this population, pediatric safety and efficacy data are lacking.
Keywords: Antifungal agents; Children; Immunocompromised hosts; Newborns.
Copyright © 2017 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
